期刊文献+

^(99)Tc^m-MAG_2-Ade肿瘤显像剂的合成及其生物活性研究 被引量:1

Synthesis and Biodistribution of ^(99)Tc^m-MAG_2-Ade as A Tumor Imaging Agent
下载PDF
导出
摘要 为了制备肿瘤显像剂99Tcm标记肽,合成并表征了新的碱基修饰的小肽配体9-[N-(S-三苯甲基巯基乙酰)二甘氨酰氨基乙基]腺嘌呤(Tr-MAG2-Ade)。通过直接标记法得到了水溶性配合物99Tcm-MAG2-Ade,并对其体外稳定性进行了检测。在荷瘤小鼠体内的生物分布结果表明,99Tcm-MAG2-Ade在肿瘤中有较高的摄取,肿瘤与肌肉的摄取比为5.7,肿瘤与血液的摄取比为1.55。血液清除较快,有望用于非腹部肿瘤的显像。 A new peptide ligand containing adenine 9-[N-(S-tritylmercaptoacetyl) diglycylaminoethyl] adenine (Tr-MAG2-Ade) is synthesized and characterized by IR, 1H NMR, 13C NMR, MS and elemental analysis. The complex 99Tcm-MAG2-Ade is prepared by directly labeling method. The partition coefficient and stability in vitro indicated that the complex is hydrophilic and stable over a period of 6 h at room temperature. The biodistribution of 99Tcm-MAG2-Ade in mice bearing S180 tumor shows that a tumor-specific accumulation and quick blood clearance. The uptake ratios of tumor to muscle and blood at 3 hours post injection are 5.70 and 1.55, respectively. The complex 99Tcm-MAG2-Ade appears to be a potential tumor imaging agent.
出处 《核化学与放射化学》 EI CAS CSCD 北大核心 2005年第2期82-86,共5页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(20171008和20371009) 北京师范大学青年科学基金(理科)资助项目(107197)
关键词 肿瘤显像剂 碱基 生物分布 tumor imaging agent peptide biological base biodistribution
  • 相关文献

参考文献9

  • 1Weiner R E, Thakur M L. Radiolabeled Peptides in the Diagnosis and Therapy of Oncological Diseases[J]. Appl Radiat Isot,2002, 57:749~763.
  • 2Chen X Y, Park R, Shahinian A H, et al. 18F-La-beled RGD Peptide:Initial Evaluation for Imaging Brain Tumor Angiogenesis [J]. Nucl Med Biol,2004, 31:179~189.
  • 3McAfee J G,Neumann R D. Radiolabeled Peptides and Other Ligands for Receptors Overexpressed in Tumor Cells for Imaging Neoplasms[J]. Nucl Med Biol, 1996, 23:673~676.
  • 4Liu S, Edwards S. ^99Tc^m-Labeled Small Peptides as Diagnostic Radiopharmaceuticals [J]. Chem Rev, 1999, 99:2 235~2 268.
  • 5Okarvi S M. Recent Development in ^99Tc^m-Labeled Peptide Based Radiopharmaceuticals: An Overview[J]. Nucl Med Comm, 1999, 20:1 093~1 113.
  • 6Behr T M. Imaging Tumors With Peptide-Based Radioligands[J]. Quart J Nucl Med, 2001,45(2):189~200.
  • 7张华北,李波,齐传民,谢懿,郭雪峰,戴梅,刘伯里.^(99)Tc^m-膦混配配合物的制备和生物分布[J].核化学与放射化学,2002,24(2):84-90. 被引量:6
  • 8Schneider R F, Subramanian G, Feld T A, et al.N,N'-bis(S-Benzoylmercaptiaetamido) Ethylenediamine and Propylenediamine Ligands as Renal Function Imaging Agents[J]. J Nucl Med, 1984, 25:223~229.
  • 9Ilgan S, David J, Yang P D, et al. Imaging Tumor Folate Receptor Using ^111In-DTPA-Methotrexate [J]. Cancer Biother Radiopham, 1998, 13:427.

二级参考文献7

  • 1VANDERHEYDEN J L,KARREN L,DENNIS LN,et al.Preparation and Characterization of [99mTc(DMPE)2 X2 ] (DMPE= 1, 2-bis(dimethylphosphino)ethane)[].International Journal of Applied Radiation and Isotopes.1983
  • 2ILGAN S,DAVID J,YANG,P D,et al.Imaging Tumor Folate Receptrs Using 111 In-DTPAMethotrexate[].Cancer Biotherapy.1998
  • 3GERSON MC,MILLAND RW,MAGORON AJ,et al.Myocardial Uptake and Kinetic Properties of Technetium-99m-Q3 in Dogs[].The Journal of Nuclear Medicine.1994
  • 4Vavourki H,Papadopoulos M,Mastrostamatis S,et al.Preparation and Bio-distribution of Cationic Complex[TcⅢ (sacac)2 (PPh)3 ]+[].The Journal of Nuclear Medicine.1992
  • 5DODONOV J,MEDOS H.Preparation of Tetraphynylphonium Salts[]..1928
  • 6SCHNEIDER R F,SUBRAMANIAN G,FELD T A,et al.N, N′-bis(S-Benzoylmercaptoacet Amido)Ethylenediamine and Propylenediamine Ligands as Renal Function Imaging Agents[].The Journal of Nuclear Medicine.1984
  • 7DEUTSCH E,VANDERHEYDEN JL,GERUNDINI P,et al.Development of Nonreducible Technetium99m ( Ⅲ) Cations as Myocardial Perfusion Imaging Agents: Initial Experimence in Humans[].The Journal of Nuclear Medicine.1987

共引文献5

同被引文献44

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部